Patient who received breast cancer vaccine as part of clinical trial speaks about experience

For the first time, we’re hearing directly from one of the few women in the country who received that vaccine as part of a clinical trial, offering a glimpse into what could become a breakthrough for...

Vaccine aimed at preventing and treating aggressive breast cancer being tested

A vaccine designed to prevent and treat one of the most aggressive forms of breast cancer is being tested at the Cleveland Clinic. It aims to train the immune system to recognize and attack cancer...

Breast cancer vaccine is in clinical trials: NC patient says it’s working

A North Carolina woman says a preventive breast cancer vaccine being tested at the Cleveland Clinic is working for her.

Fireside Chat: Anixa Biosciences, Inc (ANIX)

Cleveland Clinic advances promising breast cancer vaccine to second phase trial

Researchers at Cleveland Clinic and Anixa Biosciences are testing a new breast cancer vaccine that was safe in early trials and triggered a strong immune response in most participants. The next phase...

Breast Cancer: Triple-negative breast cancer vaccine shows promise in phase 1 clinical trial | -...

Breast cancer, one of the most aggressive kinds of cancer, remains the most commonly diagnosed cancer among women globally. In 2022 alone, around 2.3 .

Triple-negative breast cancer vaccine shows promise in early clinical trial

In a Phase 1 trial, women responded well to the novel vaccine. More research is needed to determine whether it can stop the cancer from recurring or possibly prevent it entirely.

Cleveland Clinic researchers share promising results from experimental breast cancer vaccine trial

After decades of research, Phase 1 of a Cleveland Clinic study shows a breast cancer vaccine is safe and triggers an immune response in most patients.